Factors predictive of response to interferon therapy in children with chronic hepatitis B

https://doi.org/10.1016/0168-8278(95)80448-XGet rights and content

Abstract

Background/Aims: The efficacy of interferon therapy in Caucasian children with chronic hepatitis B is similar to the in adults. However, little information is available about factors predicting response to this therapy in children. We have performed a univariate analysis to assess the strength of association between basal variables and response, and a multivariate analysis to determine the combination of basal variables which give the best prediction of response in terms of sensitivity and specificity.

Methods: The basal parameters were studied in 50 children included in three different trials of interferon alpha therapy (360–700 MU/square meter of body surface, 2 or 3 times weekly for 12 to 24 weeks).

Results: Of these, 18 (36%) were responders. In the univariate analysis, a higher histological activity (p<0.05), a lower percentage of HBcAg-stained hepatocytes (p<0.001), aspartate amino transferase and alanine aminotransferase levels (p<0.05) and alanine aminotransferase peak prior to serum HBV-DNA clearance (p<0.05), were associated to the response. In the multivariate analysis, the combinations of the percentage of HBcAg stained cells with alanine aminotransferase levels and with the histological activity index were the best variables for predicting response (sensitivity: 100% and specificity: 89% and 86%, respectively).

Conclusions: Factors predictive of response in children with chronic hepatitis B are similar to those found in adults, and may help in identifying those children with a better chance of responding.

References (19)

There are more references available in the full text version of this article.

Cited by (28)

  • Hepatitis B virus infection

    2007, Seminars in Fetal and Neonatal Medicine
    Citation Excerpt :

    Transient growth suppression in some young children may occur during therapy. In patients with elevated aminotrans-ferase levels, the results of interferon treatment are similar to those in adults, with the rate of HBe seroconversion and normalisation of aminotransferase levels being 20–40% higher in the treatment group than in the control group.41–46 A systematic meta-analysis of the literature has shown a significant benefit of interferon therapy for chronic HBV infection in children.47

  • Interferon treatment for chronic hepatitis B: Enhanced response in children 5 years old or younger

    2004, Journal of Pediatrics
    Citation Excerpt :

    Pretreatment factors that are reported correlate with a higher likelihood of response to IFN in HBV-infected adults include high pretreatment ALT levels, low HBV-DNA levels, and female sex.9 Similar pretreatment factors have been associated with response to IFN treatment in children.10,11 Our patients had many of these pretreatment factors: a high level of ALT activity at entry, a relatively low HBV-DNA concentration, and absence of cirrhosis.

View all citing articles on Scopus
View full text